ab61797 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab61797 は 5 報の論文で使用されています。

  • Quotti Tubi L  et al. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity. J Hematol Oncol 6:78 (2013). WB ; Human . PubMed: 24283803
  • Xavier CP  et al. Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration. Sci Rep 2:241 (2012). WB ; Mouse . PubMed: 22355754
  • Manni S  et al. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response. Clin Cancer Res 18:1888-900 (2012). WB . PubMed: 22351691
  • Zanin S  et al. Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells. PLoS One 7:e49193 (2012). WB . PubMed: 23145120
  • Wang X  et al. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 106:21288-93 (2009). PubMed: 19965370

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"